ID   BMR1A_HUMAN             Reviewed;         532 AA.
AC   P36894; A8K6U9; Q8NEN8;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 2.
DT   12-OCT-2022, entry version 241.
DE   RecName: Full=Bone morphogenetic protein receptor type-1A;
DE            Short=BMP type-1A receptor;
DE            Short=BMPR-1A;
DE            EC=2.7.11.30;
DE   AltName: Full=Activin receptor-like kinase 3;
DE            Short=ALK-3;
DE   AltName: Full=Serine/threonine-protein kinase receptor R5;
DE            Short=SKR5;
DE   AltName: CD_antigen=CD292;
DE   Flags: Precursor;
GN   Name=BMPR1A; Synonyms=ACVRLK3, ALK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-2.
RC   TISSUE=Placenta;
RX   PubMed=8397373;
RA   ten Dijke P., Ichijo H., Franzen P., Schulz P., Saras J., Toyoshima H.,
RA   Heldin C.-H., Miyazono K.;
RT   "Activin receptor-like kinases: a novel subclass of cell-surface receptors
RT   with predicted serine/threonine kinase activity.";
RL   Oncogene 8:2879-2887(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-2.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH BMP4.
RX   PubMed=8006002; DOI=10.1016/s0021-9258(17)32506-1;
RA   ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M.,
RA   Riddle D.L., Ichijo H., Heldin C.H., Miyazono K.;
RT   "Identification of type I receptors for osteogenic protein-1 and bone
RT   morphogenetic protein-4.";
RL   J. Biol. Chem. 269:16985-16988(1994).
RN   [5]
RP   INTERACTION WITH BMP2, AND MUTAGENESIS OF 107-ASP--GLN-109.
RX   PubMed=22799562; DOI=10.1021/bi300942x;
RA   Mahlawat P., Ilangovan U., Biswas T., Sun L.Z., Hinck A.P.;
RT   "Structure of the Alk1 extracellular domain and characterization of its
RT   bone morphogenetic protein (BMP) binding properties.";
RL   Biochemistry 51:6328-6341(2012).
RN   [6]
RP   INTERACTION WITH GDF5.
RX   PubMed=24098149; DOI=10.1371/journal.pgen.1003846;
RA   Degenkolbe E., Konig J., Zimmer J., Walther M., Reissner C., Nickel J.,
RA   Ploger F., Raspopovic J., Sharpe J., Dathe K., Hecht J.T., Mundlos S.,
RA   Doelken S.C., Seemann P.;
RT   "A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.";
RL   PLoS Genet. 9:E1003846-E1003846(2013).
RN   [7]
RP   INTERACTION WITH SCUBE3.
RX   PubMed=33308444; DOI=10.1016/j.ajhg.2020.11.015;
RG   Genomics England Research Consortium;
RA   Lin Y.C., Niceta M., Muto V., Vona B., Pagnamenta A.T., Maroofian R.,
RA   Beetz C., van Duyvenvoorde H., Dentici M.L., Lauffer P., Vallian S.,
RA   Ciolfi A., Pizzi S., Bauer P., Gruening N.M., Bellacchio E.,
RA   Del Fattore A., Petrini S., Shaheen R., Tiosano D., Halloun R.,
RA   Pode-Shakked B., Albayrak H.M., Isik E., Wit J.M., Dittrich M.,
RA   Freire B.L., Bertola D.R., Jorge A.A.L., Barel O., Sabir A.H.,
RA   Al Tenaiji A.M.J., Taji S.M., Al-Sannaa N., Al-Abdulwahed H., Digilio M.C.,
RA   Irving M., Anikster Y., Bhavani G.S.L., Girisha K.M., Haaf T., Taylor J.C.,
RA   Dallapiccola B., Alkuraya F.S., Yang R.B., Tartaglia M.;
RT   "SCUBE3 loss-of-function causes a recognizable recessive developmental
RT   disorder due to defective bone morphogenetic protein signaling.";
RL   Am. J. Hum. Genet. 108:115-133(2021).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 55-143 IN COMPLEX WITH BMP2,
RP   DISULFIDE BOND, AND INTERACTION WITH BMP2.
RX   PubMed=10881198; DOI=10.1038/75903;
RA   Kirsch T., Sebald W., Dreyer M.K.;
RT   "Crystal structure of the BMP-2-BRIA ectodomain complex.";
RL   Nat. Struct. Biol. 7:492-496(2000).
RN   [9] {ECO:0007744|PDB:1REW}
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 24-152, AND INTERACTION WITH
RP   BMP2.
RX   PubMed=15064755; DOI=10.1038/nsmb756;
RA   Keller S., Nickel J., Zhang J.L., Sebald W., Mueller T.D.;
RT   "Molecular recognition of BMP-2 and BMP receptor IA.";
RL   Nat. Struct. Mol. Biol. 11:481-488(2004).
RN   [10] {ECO:0007744|PDB:2H62, ECO:0007744|PDB:2H64}
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 24-152, AND INTERACTION WITH
RP   BMP2.
RX   PubMed=17295905; DOI=10.1186/1472-6807-7-6;
RA   Weber D., Kotzsch A., Nickel J., Harth S., Seher A., Mueller U., Sebald W.,
RA   Mueller T.D.;
RT   "A silent H-bond can be mutationally activated for high-affinity
RT   interaction of BMP-2 and activin type IIB receptor.";
RL   BMC Struct. Biol. 7:6-6(2007).
RN   [11]
RP   DISEASE.
RX   PubMed=11381269; DOI=10.1038/88919;
RA   Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A.,
RA   Petersen G.M., Velculescu V.E., Traverso G., Vogelstein B.;
RT   "Germline mutations of the gene encoding bone morphogenetic protein
RT   receptor 1A in juvenile polyposis.";
RL   Nat. Genet. 28:184-187(2001).
RN   [12]
RP   STRUCTURE BY NMR OF 51-152, DISULFIDE BONDS, AND INTERACTION WITH BMP2.
RX   PubMed=18937504; DOI=10.1021/bi801059j;
RA   Klages J., Kotzsch A., Coles M., Sebald W., Nickel J., Muller T.,
RA   Kessler H.;
RT   "The solution structure of BMPR-IA reveals a local disorder-to-order
RT   transition upon BMP-2 binding.";
RL   Biochemistry 47:11930-11939(2008).
RN   [13]
RP   VARIANTS JPS ARG-124; ASP-338 AND TYR-376.
RX   PubMed=11536076; DOI=10.1086/323703;
RA   Zhou X.-P., Woodford-Richens K., Lehtonen R., Kurose K., Aldred M.,
RA   Hampel H., Launonen V., Virta S., Pilarski R., Salovaara R., Bodmer W.F.,
RA   Conrad B.A., Dunlop M., Hodgson S.V., Iwama T., Jaervinen H.,
RA   Kellokumpu I., Kim J.C., Leggett B., Markie D., Mecklin J.-P., Neale K.,
RA   Phillips R., Piris J., Rozen P., Houlston R.S., Aaltonen L.A.,
RA   Tomlinson I.P.M., Eng C.;
RT   "Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile
RT   polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.";
RL   Am. J. Hum. Genet. 69:704-711(2001).
RN   [14]
RP   VARIANTS JPS ASP-62; TYR-82 AND CYS-443.
RX   PubMed=12417513; DOI=10.1007/bf02557528;
RA   Sayed M.G., Ahmed A.F., Ringold J.R., Anderson M.E., Bair J.L.,
RA   Mitros F.A., Lynch H.T., Tinley S.T., Petersen G.M., Giardiello F.M.,
RA   Vogelstein B., Howe J.R.;
RT   "Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis.";
RL   Ann. Surg. Oncol. 9:901-906(2002).
RN   [15]
RP   VARIANT JPS ARG-130.
RX   PubMed=12136244; DOI=10.1007/s00439-002-0748-9;
RA   Friedl W., Uhlhaas S., Schulmann K., Stolte M., Loff S., Back W.,
RA   Mangold E., Stern M., Knaebel H.P., Sutter C., Weber R.G., Pistorius S.,
RA   Burger B., Propping P.;
RT   "Juvenile polyposis: massive gastric polyposis is more common in MADH4
RT   mutation carriers than in BMPR1A mutation carriers.";
RL   Hum. Genet. 111:108-111(2002).
RN   [16]
RP   VARIANT JPS THR-470.
RX   PubMed=12630959; DOI=10.1034/j.1399-0004.2003.00008.x;
RA   Kim I.J., Park J.H., Kang H.C., Kim K.H., Kim J.H., Ku J.L., Kang S.B.,
RA   Park S.Y., Lee J.S., Park J.G.;
RT   "Identification of a novel BMPR1A germline mutation in a Korean juvenile
RT   polyposis patient without SMAD4 mutation.";
RL   Clin. Genet. 63:126-130(2003).
RN   [17]
RP   INVOLVEMENT IN JUVENILE POLYPOSIS OF INFANCY.
RX   PubMed=16685657; DOI=10.1086/504301;
RA   Delnatte C., Sanlaville D., Mougenot J.-F., Vermeesch J.-R., Houdayer C.,
RA   Blois M.-C., Genevieve D., Goulet O., Fryns J.-P., Jaubert F., Vekemans M.,
RA   Lyonnet S., Romana S., Eng C., Stoppa-Lyonnet D.;
RT   "Contiguous gene deletion within chromosome arm 10q is associated with
RT   juvenile polyposis of infancy, reflecting cooperation between the BMPR1A
RT   and PTEN tumor-suppressor genes.";
RL   Am. J. Hum. Genet. 78:1066-1074(2006).
RN   [18]
RP   INVOLVEMENT IN HEREDITARY MIXED POLYPOSIS SYNDROME 2.
RX   PubMed=16525031; DOI=10.1136/jmg.2005.034827;
RA   Cao X., Eu K.W., Kumarasinghe M.P., Li H.H., Loi C., Cheah P.Y.;
RT   "Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23
RT   by genomewide high-density single nucleotide polymorphism (SNP) scan and
RT   identification of BMPR1A loss of function.";
RL   J. Med. Genet. 43:E13-E13(2006).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-2; TYR-58; CYS-443; MET-450 AND
RP   GLN-486.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [20]
RP   VARIANT THR-460.
RX   PubMed=25860647; DOI=10.1007/s10689-015-9803-2;
RA   Hansen M.F., Johansen J., Bjoernevoll I., Sylvander A.E., Steinsbekk K.S.,
RA   Saetrom P., Sandvik A.K., Drabloes F., Sjursen W.;
RT   "A novel POLE mutation associated with cancers of colon, pancreas, ovaries
RT   and small intestine.";
RL   Fam. Cancer 14:437-448(2015).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting of two
CC       type II and two type I transmembrane serine/threonine kinases. Type II
CC       receptors phosphorylate and activate type I receptors which
CC       autophosphorylate, then bind and activate SMAD transcriptional
CC       regulators. Receptor for BMP2, BMP4, GDF5 and GDF6. Positively
CC       regulates chondrocyte differentiation through GDF5 interaction.
CC       Mediates induction of adipogenesis by GDF6.
CC       {ECO:0000250|UniProtKB:P36895}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[receptor-protein] = ADP + H(+) + O-phospho-
CC         L-threonyl-[receptor-protein]; Xref=Rhea:RHEA:44880, Rhea:RHEA-
CC         COMP:11024, Rhea:RHEA-COMP:11025, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977,
CC         ChEBI:CHEBI:456216; EC=2.7.11.30;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[receptor-protein] = ADP + H(+) + O-phospho-L-
CC         seryl-[receptor-protein]; Xref=Rhea:RHEA:18673, Rhea:RHEA-COMP:11022,
CC         Rhea:RHEA-COMP:11023, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;
CC         EC=2.7.11.30;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with BMP2 (PubMed:10881198, PubMed:15064755,
CC       PubMed:17295905, PubMed:18937504). Interacts with low affinity with
CC       GDF5; positively regulates chondrocyte differentiation
CC       (PubMed:24098149). Interacts with BMP4 (PubMed:8006002). Interacts with
CC       SCUBE3 (PubMed:33308444). {ECO:0000269|PubMed:10881198,
CC       ECO:0000269|PubMed:18937504, ECO:0000269|PubMed:24098149,
CC       ECO:0000269|PubMed:33308444, ECO:0000269|PubMed:8006002}.
CC   -!- INTERACTION:
CC       P36894; P12643: BMP2; NbExp=17; IntAct=EBI-1029237, EBI-1029262;
CC       P36894; P12644: BMP4; NbExp=2; IntAct=EBI-1029237, EBI-1998134;
CC       P36894; P43026: GDF5; NbExp=4; IntAct=EBI-1029237, EBI-8571476;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P36898};
CC       Single-pass type I membrane protein {ECO:0000255}. Cell surface
CC       {ECO:0000250|UniProtKB:P36895}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:P36895}.
CC   -!- DISEASE: Juvenile polyposis syndrome (JPS) [MIM:174900]: Autosomal
CC       dominant gastrointestinal hamartomatous polyposis syndrome in which
CC       patients are at risk for developing gastrointestinal cancers. The
CC       lesions are typified by a smooth histological appearance, predominant
CC       stroma, cystic spaces and lack of a smooth muscle core. Multiple
CC       juvenile polyps usually occur in a number of Mendelian disorders.
CC       Sometimes, these polyps occur without associated features as in JPS;
CC       here, polyps tend to occur in the large bowel and are associated with
CC       an increased risk of colon and other gastrointestinal cancers.
CC       {ECO:0000269|PubMed:11536076, ECO:0000269|PubMed:12136244,
CC       ECO:0000269|PubMed:12417513, ECO:0000269|PubMed:12630959}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Polyposis syndrome, mixed hereditary 2 (HMPS2) [MIM:610069]: A
CC       disease is characterized by atypical juvenile polyps, colonic adenomas,
CC       and colorectal carcinomas. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A microdeletion of chromosome 10q23 involving BMPR1A and
CC       PTEN is a cause of chromosome 10q23 deletion syndrome, which shows
CC       overlapping features of the following three disorders: Bannayan-Zonana
CC       syndrome, Cowden disease and juvenile polyposis syndrome.
CC       {ECO:0000269|PubMed:11381269, ECO:0000269|PubMed:16525031}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z22535; CAA80257.1; -; mRNA.
DR   EMBL; AK291764; BAF84453.1; -; mRNA.
DR   EMBL; BC028383; AAH28383.1; -; mRNA.
DR   CCDS; CCDS7378.1; -.
DR   PIR; I37163; I37163.
DR   RefSeq; NP_004320.2; NM_004329.2.
DR   RefSeq; XP_011538405.1; XM_011540103.2.
DR   RefSeq; XP_011538406.1; XM_011540104.2.
DR   PDB; 1ES7; X-ray; 2.90 A; B/D=55-143.
DR   PDB; 1REW; X-ray; 1.86 A; C/D=24-152.
DR   PDB; 2GOO; X-ray; 2.20 A; B/E=24-152.
DR   PDB; 2H62; X-ray; 1.85 A; C=24-152.
DR   PDB; 2H64; X-ray; 1.92 A; B=24-152.
DR   PDB; 2K3G; NMR; -; A=51-152.
DR   PDB; 2QJ9; X-ray; 2.44 A; C/D=24-152.
DR   PDB; 2QJA; X-ray; 2.60 A; C/D=24-152.
DR   PDB; 2QJB; X-ray; 2.50 A; C/D=24-152.
DR   PDB; 3NH7; X-ray; 2.70 A; A/B/C/D=24-152.
DR   PDB; 3QB4; X-ray; 2.28 A; B/D=24-152.
DR   PDBsum; 1ES7; -.
DR   PDBsum; 1REW; -.
DR   PDBsum; 2GOO; -.
DR   PDBsum; 2H62; -.
DR   PDBsum; 2H64; -.
DR   PDBsum; 2K3G; -.
DR   PDBsum; 2QJ9; -.
DR   PDBsum; 2QJA; -.
DR   PDBsum; 2QJB; -.
DR   PDBsum; 3NH7; -.
DR   PDBsum; 3QB4; -.
DR   AlphaFoldDB; P36894; -.
DR   BMRB; P36894; -.
DR   SMR; P36894; -.
DR   BioGRID; 107125; 210.
DR   CORUM; P36894; -.
DR   DIP; DIP-5793N; -.
DR   IntAct; P36894; 65.
DR   MINT; P36894; -.
DR   STRING; 9606.ENSP00000361107; -.
DR   BindingDB; P36894; -.
DR   ChEMBL; CHEMBL5275; -.
DR   DrugBank; DB11639; Dibotermin alfa.
DR   DrugCentral; P36894; -.
DR   GuidetoPHARMACOLOGY; 1786; -.
DR   GlyGen; P36894; 1 site.
DR   iPTMnet; P36894; -.
DR   PhosphoSitePlus; P36894; -.
DR   SwissPalm; P36894; -.
DR   BioMuta; BMPR1A; -.
DR   DMDM; 61252444; -.
DR   EPD; P36894; -.
DR   jPOST; P36894; -.
DR   MassIVE; P36894; -.
DR   MaxQB; P36894; -.
DR   PaxDb; P36894; -.
DR   PeptideAtlas; P36894; -.
DR   PRIDE; P36894; -.
DR   ProteomicsDB; 55228; -.
DR   ABCD; P36894; 1 sequenced antibody.
DR   Antibodypedia; 4524; 797 antibodies from 38 providers.
DR   DNASU; 657; -.
DR   Ensembl; ENST00000372037.8; ENSP00000361107.2; ENSG00000107779.14.
DR   Ensembl; ENST00000635816.1; ENSP00000489707.1; ENSG00000107779.14.
DR   Ensembl; ENST00000636056.1; ENSP00000490273.1; ENSG00000107779.14.
DR   Ensembl; ENST00000638429.1; ENSP00000492290.1; ENSG00000107779.14.
DR   GeneID; 657; -.
DR   KEGG; hsa:657; -.
DR   MANE-Select; ENST00000372037.8; ENSP00000361107.2; NM_004329.3; NP_004320.2.
DR   UCSC; uc001kdy.4; human.
DR   CTD; 657; -.
DR   DisGeNET; 657; -.
DR   GeneCards; BMPR1A; -.
DR   GeneReviews; BMPR1A; -.
DR   HGNC; HGNC:1076; BMPR1A.
DR   HPA; ENSG00000107779; Low tissue specificity.
DR   MalaCards; BMPR1A; -.
DR   MIM; 174900; phenotype.
DR   MIM; 601299; gene.
DR   MIM; 610069; phenotype.
DR   MIM; 612242; phenotype.
DR   neXtProt; NX_P36894; -.
DR   OpenTargets; ENSG00000107779; -.
DR   Orphanet; 440437; Familial colorectal cancer Type X.
DR   Orphanet; 329971; Generalized juvenile polyposis/juvenile polyposis coli.
DR   Orphanet; 157794; Hereditary mixed polyposis syndrome.
DR   Orphanet; 79076; Juvenile polyposis of infancy.
DR   PharmGKB; PA25386; -.
DR   VEuPathDB; HostDB:ENSG00000107779; -.
DR   eggNOG; KOG2052; Eukaryota.
DR   GeneTree; ENSGT00940000156225; -.
DR   HOGENOM; CLU_000288_8_1_1; -.
DR   InParanoid; P36894; -.
DR   OMA; VMGPFFD; -.
DR   OrthoDB; 776697at2759; -.
DR   PhylomeDB; P36894; -.
DR   TreeFam; TF314724; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; P36894; -.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   SignaLink; P36894; -.
DR   SIGNOR; P36894; -.
DR   BioGRID-ORCS; 657; 84 hits in 1108 CRISPR screens.
DR   ChiTaRS; BMPR1A; human.
DR   EvolutionaryTrace; P36894; -.
DR   GeneWiki; BMPR1A; -.
DR   GenomeRNAi; 657; -.
DR   Pharos; P36894; Tchem.
DR   PRO; PR:P36894; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P36894; protein.
DR   Bgee; ENSG00000107779; Expressed in secondary oocyte and 209 other tissues.
DR   ExpressionAtlas; P36894; baseline and differential.
DR   Genevisible; P36894; HS.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:1990712; C:HFE-transferrin receptor complex; IC:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC-UCL.
DR   GO; GO:0036122; F:BMP binding; IEA:Ensembl.
DR   GO; GO:0098821; F:BMP receptor activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019211; F:phosphatase activator activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC-UCL.
DR   GO; GO:0046332; F:SMAD binding; IDA:HGNC-UCL.
DR   GO; GO:0005025; F:transforming growth factor beta receptor activity, type I; IBA:GO_Central.
DR   GO; GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0060928; P:atrioventricular node cell development; ISS:BHF-UCL.
DR   GO; GO:0003171; P:atrioventricular valve development; ISS:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0061312; P:BMP signaling pathway involved in heart development; ISS:BHF-UCL.
DR   GO; GO:0003161; P:cardiac conduction system development; ISS:BHF-UCL.
DR   GO; GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IMP:BHF-UCL.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IBA:GO_Central.
DR   GO; GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0048589; P:developmental growth; IEA:Ensembl.
DR   GO; GO:0035912; P:dorsal aorta morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IBA:GO_Central.
DR   GO; GO:0007398; P:ectoderm development; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0048568; P:embryonic organ development; ISS:BHF-UCL.
DR   GO; GO:0003272; P:endocardial cushion formation; ISS:BHF-UCL.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:1905285; P:fibrous ring of heart morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060914; P:heart formation; IEA:Ensembl.
DR   GO; GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IMP:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0048368; P:lateral mesoderm development; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0048382; P:mesendoderm development; IEA:Ensembl.
DR   GO; GO:0001707; P:mesoderm formation; IEA:Ensembl.
DR   GO; GO:0003183; P:mitral valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0001880; P:Mullerian duct regression; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISS:BHF-UCL.
DR   GO; GO:0051148; P:negative regulation of muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IMP:BHF-UCL.
DR   GO; GO:0014032; P:neural crest cell development; IEA:Ensembl.
DR   GO; GO:0021998; P:neural plate mediolateral regionalization; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0048352; P:paraxial mesoderm structural organization; IEA:Ensembl.
DR   GO; GO:0061626; P:pharyngeal arch artery morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL.
DR   GO; GO:1904414; P:positive regulation of cardiac ventricle development; ISS:BHF-UCL.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; IEA:Ensembl.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0032915; P:positive regulation of transforming growth factor beta2 production; ISS:BHF-UCL.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:HGNC-UCL.
DR   GO; GO:0060043; P:regulation of cardiac muscle cell proliferation; ISS:BHF-UCL.
DR   GO; GO:2000772; P:regulation of cellular senescence; IEA:Ensembl.
DR   GO; GO:0048378; P:regulation of lateral mesodermal cell fate specification; IEA:Ensembl.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0003186; P:tricuspid valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003223; P:ventricular compact myocardium morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISS:BHF-UCL.
DR   DisProt; DP01990; -.
DR   Gene3D; 2.10.60.10; -; 1.
DR   InterPro; IPR000472; Activin_recp.
DR   InterPro; IPR003605; GS_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   InterPro; IPR000333; TGFB_receptor.
DR   PANTHER; PTHR23255; PTHR23255; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF08515; TGF_beta_GS; 1.
DR   SMART; SM00467; GS; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57302; SSF57302; 1.
DR   PROSITE; PS51256; GS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Disease variant; Disulfide bond;
KW   Glycoprotein; Kinase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Receptor; Reference proteome;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..532
FT                   /note="Bone morphogenetic protein receptor type-1A"
FT                   /id="PRO_0000024410"
FT   TOPO_DOM        24..152
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..176
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        177..532
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          204..233
FT                   /note="GS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00585"
FT   DOMAIN          234..525
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          107..109
FT                   /note="Mediates specificity for BMP ligand"
FT                   /evidence="ECO:0000269|PubMed:22799562"
FT   ACT_SITE        362
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         240..248
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         261
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        61..82
FT                   /evidence="ECO:0000269|PubMed:10881198,
FT                   ECO:0000269|PubMed:18937504"
FT   DISULFID        63..67
FT                   /evidence="ECO:0000269|PubMed:10881198,
FT                   ECO:0000269|PubMed:18937504"
FT   DISULFID        76..100
FT                   /evidence="ECO:0000269|PubMed:10881198,
FT                   ECO:0000269|PubMed:18937504"
FT   DISULFID        110..124
FT                   /evidence="ECO:0000269|PubMed:10881198,
FT                   ECO:0000269|PubMed:18937504"
FT   DISULFID        125..130
FT                   /evidence="ECO:0000269|PubMed:10881198,
FT                   ECO:0000269|PubMed:18937504"
FT   VARIANT         2
FT                   /note="P -> T (in dbSNP:rs11528010)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8397373"
FT                   /id="VAR_041397"
FT   VARIANT         58
FT                   /note="F -> Y (in a renal clear cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041398"
FT   VARIANT         62
FT                   /note="Y -> D (in JPS)"
FT                   /evidence="ECO:0000269|PubMed:12417513"
FT                   /id="VAR_022828"
FT   VARIANT         82
FT                   /note="C -> Y (in JPS)"
FT                   /evidence="ECO:0000269|PubMed:12417513"
FT                   /id="VAR_022829"
FT   VARIANT         124
FT                   /note="C -> R (in JPS; dbSNP:rs199476087)"
FT                   /evidence="ECO:0000269|PubMed:11536076"
FT                   /id="VAR_015533"
FT   VARIANT         130
FT                   /note="C -> R (in JPS; dbSNP:rs1131691168)"
FT                   /evidence="ECO:0000269|PubMed:12136244"
FT                   /id="VAR_022830"
FT   VARIANT         338
FT                   /note="A -> D (in JPS; dbSNP:rs199476086)"
FT                   /evidence="ECO:0000269|PubMed:11536076"
FT                   /id="VAR_015534"
FT   VARIANT         376
FT                   /note="C -> Y (in JPS; dbSNP:rs199476088)"
FT                   /evidence="ECO:0000269|PubMed:11536076"
FT                   /id="VAR_015535"
FT   VARIANT         443
FT                   /note="R -> C (in JPS; dbSNP:rs35619497)"
FT                   /evidence="ECO:0000269|PubMed:12417513,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_022831"
FT   VARIANT         450
FT                   /note="V -> M (in dbSNP:rs55932635)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041399"
FT   VARIANT         460
FT                   /note="M -> T (found in a patient with tubular adenoma and
FT                   rectal neuroendocrine tumor; unknown pathological
FT                   significance; dbSNP:rs758309022)"
FT                   /evidence="ECO:0000269|PubMed:25860647"
FT                   /id="VAR_077353"
FT   VARIANT         470
FT                   /note="M -> T (in JPS; dbSNP:rs199476089)"
FT                   /evidence="ECO:0000269|PubMed:12630959"
FT                   /id="VAR_022832"
FT   VARIANT         486
FT                   /note="R -> Q (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs752802257)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041400"
FT   MUTAGEN         107..109
FT                   /note="DFQ->REL: Affinity for BMP2 decreased by over
FT                   200-fold."
FT                   /evidence="ECO:0000269|PubMed:22799562"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   STRAND          75..88
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   STRAND          94..101
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   HELIX           106..111
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   STRAND          116..118
FT                   /evidence="ECO:0007829|PDB:2QJA"
FT   STRAND          120..125
FT                   /evidence="ECO:0007829|PDB:2H62"
FT   HELIX           130..133
FT                   /evidence="ECO:0007829|PDB:2H62"
SQ   SEQUENCE   532 AA;  60198 MW;  00CE2DDDA3A44170 CRC64;
     MPQLYIYIRL LGAYLFIISR VQGQNLDSML HGTGMKSDSD QKKSENGVTL APEDTLPFLK
     CYCSGHCPDD AINNTCITNG HCFAIIEEDD QGETTLASGC MKYEGSDFQC KDSPKAQLRR
     TIECCRTNLC NQYLQPTLPP VVIGPFFDGS IRWLVLLISM AVCIIAMIIF SSCFCYKHYC
     KSISSRRRYN RDLEQDEAFI PVGESLKDLI DQSQSSGSGS GLPLLVQRTI AKQIQMVRQV
     GKGRYGEVWM GKWRGEKVAV KVFFTTEEAS WFRETEIYQT VLMRHENILG FIAADIKGTG
     SWTQLYLITD YHENGSLYDF LKCATLDTRA LLKLAYSAAC GLCHLHTEIY GTQGKPAIAH
     RDLKSKNILI KKNGSCCIAD LGLAVKFNSD TNEVDVPLNT RVGTKRYMAP EVLDESLNKN
     HFQPYIMADI YSFGLIIWEM ARRCITGGIV EEYQLPYYNM VPSDPSYEDM REVVCVKRLR
     PIVSNRWNSD ECLRAVLKLM SECWAHNPAS RLTALRIKKT LAKMVESQDV KI
//
